Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioNTech SE

110.88
+0.11000.10%
Post-market: 110.880.00000.00%16:47 EDT
Volume:401.20K
Turnover:44.72M
Market Cap:26.61B
PE:-65.78
High:112.90
Open:110.75
Low:110.62
Close:110.77
52wk High:131.49
52wk Low:81.20
Shares:240.00M
Float Shares:93.81M
Volume Ratio:0.64
T/O Rate:0.43%
Dividend:0.00
Dividend Rate:0.00%
EPS(TTM):-1.6856
EPS(LYR):-2.8652
ROE:-1.84%
ROA:-2.14%
PB:1.23
PE(LYR):-38.70

Loading ...

Firebrick Pharma Secures Australian Patent for Nasodine COVID-19 Nasal Spray

TIPRANKS
·
7 hours ago

Moderna Stock Is Trading Higher Friday: What's Going On?

Benzinga
·
Aug 23

BioNTech’s Promising Phase III Study in Recurrent Endometrial Cancer

TIPRANKS
·
Aug 23

Enanta Files Patent Lawsuit Against Pfizer (PFE) Over COVID-19 Drug Paxlovid

Simply Wall St.
·
Aug 22

Covid-19 Vaccine Guidelines Are Changing. What We Know About Who Can Get a Shot. -- Barrons.com

Dow Jones
·
Aug 21

Leading Pediatrics Group Recommends Covid-19 Shots for Young Children, Differing from CDC -- WSJ

Dow Jones
·
Aug 19

Pfizer Canada, BioNTech get Health Canada approval for COVID variant vaccine

TIPRANKS
·
Aug 19

Invivyd Announces Continued Neutralizing Activity of PEMGARDA® (pemivibart) and VYD2311 Against Currently Dominant SARS-CoV-2 Variant XFG (“Stratus”)

GlobeNewswire
·
Aug 19

Traws Pharma Gains Approval for Phase 2 COVID-19 Trials

TIPRANKS
·
Aug 18

Australian court fines Qantas US$59 million for illegal COVID-19 layoffs

CNA
·
Aug 18

Fact Check: Viral Stimulus Check Claims for Summer Are False, IRS Will Not Send New Checks This Summer

Benzinga_recent_news
·
Aug 16

Viking Global Investors LP Reduces Stake in Microsoft

TIPRANKS
·
Aug 16

CureVac Reports Decrease in Net Financial Result for H1 2025; R&D Expenses Rise Amid Strategic Restructuring

Reuters
·
Aug 15

Nagarro SE (NGRRF) Gets a Buy from Warburg Research

TIPRANKS
·
Aug 15

Invivyd Revenue Jumps 413 Percent in Q2

Motley Fool
·
Aug 15

Invivyd aligns with FDA on pathway to approval of COVID-19 vaccine VYD2311

TIPRANKS
·
Aug 15

Invivyd Aligns with U.S. FDA on Rapid Pathway to Full Approval (BLA) of Vaccine Alternative Monoclonal Antibody VYD2311 to Protect American Adults and Adolescents from COVID-19

GlobeNewswire
·
Aug 15

Co-Diagnostics Sales Plunge 93 Percent

Motley Fool
·
Aug 15

BioNTech’s Promising Lung Cancer Study: A Potential Game-Changer for Investors

TIPRANKS
·
Aug 15

BioNTech Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Aug 14